It also has been reported that SPON2 protein expression are significantly higher in prostate cancer patients than in healthy individuals, and, more encouragingly, SPON2 had a stronger diagnostic performance than the percent free-to-total and total prostate-specific antigen (PSA) [8]. Here, KLK3 is linked to prostate cancer.